Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Novato, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BIOMARIN PHARMACEUTICAL INC has filed 2,740 SEC EDGAR filings since 04 May 1999

SEC filing history

Showing 876-900 of 1,000 matching filings.

Per page
25
Current page
36
8-K File 000-26727

8-K

Filing date
26 Oct 2017
Reporting date
26 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
13 Oct 2017
Reporting date
27 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
13 Oct 2017
Reporting date
16 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
13 Oct 2017
Reporting date
03 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
13 Oct 2017
Reporting date
15 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
13 Oct 2017
Reporting date
06 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
03 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26727

8-K

Filing date
03 Oct 2017
Reporting date
28 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2017
Reporting date
28 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Sep 2017
Reporting date
15 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Sep 2017
Reporting date
15 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26727

8-K

Filing date
11 Aug 2017
Reporting date
07 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-212974

424B5

Filing date
09 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-212974

FWP

Filing date
09 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
305B2 File 333-212974

305B2

Filing date
08 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-212974

424B5

Filing date
08 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jun 2017
Reporting date
23 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Jun 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Jun 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .